{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:05:14Z","timestamp":1777302314593,"version":"3.51.4"},"reference-count":48,"publisher":"China Science Publishing & Media Ltd.","issue":"5","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2023,5,1]]},"DOI":"10.3724\/abbs.2023071","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T03:10:13Z","timestamp":1681355413000},"page":"831-841","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["Bioinformatics exploration of potential common therapeutic targets for systemic and pulmonary arterial hypertension-induced myocardial hypertrophy"],"prefix":"10.3724","volume":"55","author":[{"given":"Lu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cankun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hairuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangjun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Bin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.113.008461","volume":"130","author":"Mohammed SF","year":"2014","unstructured":"Mohammed SF, Hussain I, AbouEzzeddine OF, Takahama H, Kwon SH, Forfia P, Roger VL. Right ventricular function in heart failure with preserved ejection fraction. Circulation, 2014, 130: 2310-2320.","journal-title":"Circulation"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.amjcard.2010.02.039","volume":"106","author":"Leung CC","year":"2010","unstructured":"Leung CC, Moondra V, Catherwood E, Andrus BW. Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol, 2010, 106: 284-286.","journal-title":"Am J Cardiol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","volume":"53","author":"Lam CSP","year":"2009","unstructured":"Lam CSP, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction. J Am Coll Cardiol, 2009, 53: 1119-1126.","journal-title":"J Am Coll Cardiol"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"e023603","DOI":"10.1161\/JAHA.121.023603","volume":"10","author":"Itelman E","year":"2021","unstructured":"Itelman E, Segel MJ, Kuperstein R, Feinberg M, Segev A, Segal G, Maor E. Pulmonary hypertension is associated with systemic arterial hypertension among patients with normal left ventricular diastolic function. J Am Heart Assoc, 2021, 10:","journal-title":"J Am Heart Assoc"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"e005527","DOI":"10.1161\/CIRCIMAGING.116.005527","volume":"9","author":"Hansmann G","year":"2016","unstructured":"Hansmann G. Left ventricular diastolic dysfunction in pediatric pulmonary hypertension. Circ Cardiovasc Imag, 2016, 9:","journal-title":"Circ Cardiovasc Imag"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.2022.4402","volume":"327","author":"Ruopp NF","year":"2022","unstructured":"Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension. JAMA, 2022, 327:","journal-title":"JAMA"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","volume":"119","author":"Galie\u0300 N","year":"2009","unstructured":"Galie\u0300 N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, Shapiro S. Tadalafil therapy for pulmonary arterial hypertension. Circulation, 2009, 119: 2894-2903.","journal-title":"Circulation"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1209655","volume":"369","author":"Ghofrani HA","year":"2013","unstructured":"Ghofrani HA, Gali\u00e8 N, Grimminger F, Gr\u00fcnig E, Humbert M, Jing ZC, Keogh AM. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med, 2013, 369: 330-340.","journal-title":"N Engl J Med"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","volume":"358","author":"Channick RN","year":"2001","unstructured":"Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study. Lancet, 2001, 358: 1119-1123.","journal-title":"Lancet"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"Barst RJ","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med, 1996, 334: 296-301.","journal-title":"N Engl J Med"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/annrheumdis-2019-216274","volume":"79","author":"Kuwana M","year":"2020","unstructured":"Kuwana M, Blair C, Takahashi T, Langley J, Coghlan JG. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis. Ann Rheum Dis, 2020, 79: 626-634.","journal-title":"Ann Rheum Dis"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/cvr\/cvz016","volume":"116","author":"Lin H","year":"2020","unstructured":"Lin H, Li Y, Zhu H, Wang Q, Chen Z, Chen L, Zhu Y. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of \u03b2-catenin. Cardiovasc Res, 2020, 116: 101-113.","journal-title":"Cardiovasc Res"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1161\/CIRCRESAHA.116.308688","volume":"118","author":"Zhao L","year":"2016","unstructured":"Zhao L, Cheng G, Jin R, Afzal MR, Samanta A, Xuan YT, Girgis M. Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction. Circ Res, 2016, 118: 1918-1929.","journal-title":"Circ Res"},{"key":"CITATION14","doi-asserted-by":"crossref","unstructured":"Li G, Shao Y, Guo HC, Zhi Y, Qiao B, Ma K, Lai YQ,                         et al. MicroRNA-27b-3p downregulates FGF1 and aggravates pathological cardiac remodelling.                                                      Cardiovasc Res                          2022, 118: 2139\u20132151.","DOI":"10.1093\/cvr\/cvab248"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1161\/CIRCULATIONAHA.119.040740","volume":"140","author":"Guo Y","year":"2019","unstructured":"Guo Y, Sui JY, Kim K, Zhang Z, Qu XA, Nam YJ, Willette RN. Cardiomyocyte homeodomain-interacting protein kinase 2 maintains basal cardiac function via extracellular signal-regulated kinase signaling. Circulation, 2019, 140: 1820-1833.","journal-title":"Circulation"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1152\/japplphysiol.01350.2011","volume":"112","author":"Waehre A","year":"2012","unstructured":"Waehre A, Vistnes M, Sjaastad I, Nyg\u00e5rd S, Husberg C, Lunde IG, Aukrust P. Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle. J Appl Physiol, 2012, 112: 1372-1382.","journal-title":"J Appl Physiol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"Barrett T","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res, 2013, 41: D991-D995.","journal-title":"Nucleic Acids Res"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"Lamb J","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 2006, 313: 1929-1935.","journal-title":"Science"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"12711","DOI":"10.1073\/pnas.1501597112","volume":"112","author":"Brum AM","year":"2015","unstructured":"Brum AM, van de Peppel J, van der Leije CS, Schreuders-Koedam M, Eijken M, van der Eerden BCJ, van Leeuwen JPTM. Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway. Proc Natl Acad Sci USA, 2015, 112: 12711-12716.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"Davis AP","year":"2021","unstructured":"Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, Mattingly CJ. Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res, 2021, 49: D1138-D1143.","journal-title":"Nucleic Acids Res"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"59431","DOI":"10.3791\/59431","volume":"147","author":"Wang Q","year":"2019","unstructured":"Wang Q, Chen K, Lin H, He M, Huang X, Zhu H, Liao Y. Induction of right ventricular failure by pulmonary artery constriction and evaluation of right ventricular function in mice. J Vis Exp, 2019, 147:","journal-title":"J Vis Exp"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"789493","DOI":"10.3389\/fcvm.2021.789493","volume":"8","author":"Ma S","year":"2021","unstructured":"Ma S, Yan J, Yang D, Liao W, Bin J, Lin H, Liao Y. A modified surgical ventricular reconstruction in post-infarction mice persistently alleviates heart failure and improves cardiac regeneration. Front Cardiovasc Med, 2021, 8:","journal-title":"Front Cardiovasc Med"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.18632\/aging.202385","volume":"13","author":"Chen K","year":"2021","unstructured":"Chen K, Huang X, Xie D, Shen M, Lin H, Zhu Y, Ma S. RNA interactions in right ventricular dysfunction induced type II cardiorenal syndrome. Aging, 2021, 13: 4215-4241.","journal-title":"Aging"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/cvr\/cvx001","volume":"113","author":"Chen Z","year":"2017","unstructured":"Chen Z, Xie J, Hao H, Lin H, Wang L, Zhang Y, Chen L. Ablation of periostin inhibits post-infarction myocardial regeneration in neonatal mice mediated by the phosphatidylinositol 3 kinase\/glycogen synthase kinase 3\u03b2\/cyclin D1 signalling pathway. Cardiovasc Res, 2017, 113: 620-632.","journal-title":"Cardiovasc Res"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cardfail.2020.04.011","volume":"26","author":"Tam K","year":"2020","unstructured":"Tam K, Richards DA, Aronovitz MJ, Martin GL, Pande S, Jaffe IZ, Blanton RM. Sacubitril\/valsartan improves left ventricular function in chronic pressure overload independent of intact cyclic guanosine monophosphate-dependent protein kinase i alpha signaling. J Cardiac Fail, 2020, 26: 769-775.","journal-title":"J Cardiac Fail"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ehf2.13177","volume":"8","author":"Nord\u00e9n ES","year":"2021","unstructured":"Nord\u00e9n ES, Bendiksen BA, Andresen H, Bergo KK, Espe EK, Hasic A, Hauge\u2010Iversen IM. Sacubitril\/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload. ESC Heart Fail, 2021, 8: 918-927.","journal-title":"ESC Heart Fail"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/cvr\/cvaa200","volume":"117","author":"Chaumais MC","year":"2021","unstructured":"Chaumais MC, Djessas MRA, Thuillet R, Cumont A, Tu L, Hebert G, Gaignard P. Additive protective effects of sacubitril\/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension. Cardiovasc Res, 2021, 117: 1391-1401.","journal-title":"Cardiovasc Res"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1172\/JCI87491","volume":"127","author":"Frangogiannis NG","year":"2017","unstructured":"Frangogiannis NG. The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest, 2017, 127: 1600-1612.","journal-title":"J Clin Invest"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.matbio.2018.01.013","volume":"68-69","author":"Li L","year":"2018","unstructured":"Li L, Zhao Q, Kong W. Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol, 2018, 68-69: 490-506.","journal-title":"Matrix Biol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI74783","volume":"124","author":"Moore-Morris T","year":"2014","unstructured":"Moore-Morris T, Guimar\u00e3es-Camboa N, Banerjee I, Zambon AC, Kisseleva T, Velayoudon A, Stallcup WB. Resident fibroblast lineages mediate pressure overload\u2013induced cardiac fibrosis. J Clin Invest, 2014, 124: 2921-2934.","journal-title":"J Clin Invest"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/00004872-199816090-00016","volume":"16","author":"Grimm D","year":"1998","unstructured":"Grimm D, Kromer EP, B\u00f6cker W, Bruckschlegel G, Holmer SR, Riegger GAJ, Schunkert H. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy. J Hypertens, 1998, 16: 1345-1355.","journal-title":"J Hypertens"},{"key":"CITATION32","doi-asserted-by":"crossref","unstructured":"Frangogiannis NG. Cardiac fibrosis.                                                      Cardiovasc Res                          2021, 117: 1450\u20131488.","DOI":"10.1093\/cvr\/cvaa324"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1038\/ncomms13710","volume":"7","author":"Yang J","year":"2016","unstructured":"Yang J, Savvatis K, Kang JS, Fan P, Zhong H, Schwartz K, Barry V. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat Commun, 2016, 7:","journal-title":"Nat Commun"},{"key":"CITATION34","doi-asserted-by":"crossref","unstructured":"Qin W, Cao L. Role of PI3K\/Akt signaling pathway in cardiac fibrosis.                                                      Mol Cell Biochem                          2021, 476: 4045\u20134059.","DOI":"10.1007\/s11010-021-04219-w"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"Khalil H","year":"2017","unstructured":"Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, Vagnozzi RJ. Fibroblast-specific TGF-\u03b2\u2013Smad2\/3 signaling underlies cardiac fibrosis. J Clin Invest, 2017, 127: 3770-3783.","journal-title":"J Clin Invest"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","volume":"51","author":"Dobaczewski M","year":"2011","unstructured":"Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling. J Mol Cell Cardiol, 2011, 51: 600-606.","journal-title":"J Mol Cell Cardiol"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","volume":"19","author":"Frangogiannis NG","year":"2022","unstructured":"Frangogiannis NG. Transforming growth factor-\u03b2 in myocardial disease. Nat Rev Cardiol, 2022, 19: 435-455.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/HYPERTENSIONAHA.118.12267","volume":"73","author":"Kumar S","year":"2019","unstructured":"Kumar S, Wang G, Zheng N, Cheng W, Ouyang K, Lin H, Liao Y. HIMF (hypoxia-induced mitogenic factor)-IL (interleukin)-6 signaling mediates cardiomyocyte-fibroblast crosstalk to promote cardiac hypertrophy and fibrosis. Hypertension, 2019, 73: 1058-1070.","journal-title":"Hypertension"},{"key":"CITATION39","doi-asserted-by":"crossref","unstructured":"Huo S, Shi W, Ma H, Yan D, Luo P, Guo J, Li C,                         et al. Alleviation of inflammation and oxidative stress in pressure overload-induced cardiac remodeling and heart failure via IL-6\/STAT3 inhibition by raloxifene.                                                      Oxid Med Cell Longev                          2021, 2021: 6699054.","DOI":"10.1155\/2021\/6699054"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.3390\/ijms21176421","volume":"21","author":"Pena E","year":"2020","unstructured":"Pena E, Brito J, El Alam S, Siques P. Oxidative stress, kinase activity and inflammatory implications in right ventricular hypertrophy and heart failure under hypobaric hypoxia. Int J Mol Sci, 2020, 21:","journal-title":"Int J Mol Sci"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"e018549","DOI":"10.1161\/JAHA.120.018549","volume":"10","author":"Chia YC","year":"2021","unstructured":"Chia YC, Kieneker LM, van Hassel G, Binnenmars SH, Nolte IM, van Zanden JJ, van der Meer P. Interleukin 6 and development of heart failure with preserved ejection fraction in the general population. J Am Heart Assoc, 2021, 10:","journal-title":"J Am Heart Assoc"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.matbio.2005.06.008","volume":"24","author":"Mao Y","year":"2005","unstructured":"Mao Y, Schwarzbauer JE. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol, 2005, 24: 389-399.","journal-title":"Matrix Biol"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.lfs.2018.08.009","volume":"209","author":"Suleiman M","year":"2018","unstructured":"Suleiman M, Abdulrahman N, Yalcin H, Mraiche F. The role of CD44, hyaluronan and NHE1 in cardiac remodeling. Life Sci, 2018, 209: 197-201.","journal-title":"Life Sci"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/SHK.0000000000001132","volume":"51","author":"Yang LW","year":"2019","unstructured":"Yang LW, Qin DZ, James E, McKallip RJ, Wang NP, Zhang WW, Zheng RH. CD44 deficiency in mice protects the heart against angiotensin ii-induced cardiac fibrosis. Shock, 2019, 51: 372-380.","journal-title":"Shock"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"670153","DOI":"10.3389\/fimmu.2021.670153","volume":"12","author":"Bu J","year":"2021","unstructured":"Bu J, Huang S, Wang J, Xia T, Liu H, You Y, Wang Z. The GABAA receptor influences pressure overload-induced heart failure by modulating macrophages in mice. Front Immunol, 2021, 12:","journal-title":"Front Immunol"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1586\/ecp.10.136","volume":"4","author":"John J","year":"2011","unstructured":"John J, Palevsky H. Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension. Expert Rev Clin Pharmacol, 2011, 4: 197-205.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1183\/09031936.00188013","volume":"45","author":"Gomez-Arroyo J","year":"2015","unstructured":"Gomez-Arroyo J, Sakagami M, Syed AA, Farkas L, Van Tassell B, Kraskauskas D, Mizuno S. Iloprost reverses established fibrosis in experimental right ventricular failure. Eur Respir J, 2015, 45: 449-462.","journal-title":"Eur Respir J"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41419-021-04152-2","volume":"12","author":"Zou Y","year":"2021","unstructured":"Zou Y, Pan L, Shen Y, Wang X, Huang C, Wang H, Jin X. Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload. Cell Death Dis, 2021, 12:","journal-title":"Cell Death Dis"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/76F434D48988406F9001615B1AAB8BED","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2023071","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/76F434D48988406F9001615B1AAB8BED","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T07:38:49Z","timestamp":1687246729000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2023071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,25]]},"published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2023071","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,1]]}}}